Pages that link to "Q44737326"
Jump to navigation
Jump to search
The following pages link to Erythropoietin protects against ischaemic acute renal injury (Q44737326):
Displaying 50 items.
- Erythropoietin protects cardiomyocytes from cell death during hypoxia/reperfusion injury through activation of survival signaling pathways (Q27347504) (← links)
- Molecular mechanisms of ischemic preconditioning in the kidney (Q28080772) (← links)
- Chronic renal ischemia in humans: can cell therapy repair the kidney in occlusive renovascular disease? (Q28085141) (← links)
- Hypoxia-inducible factors in the kidney (Q28303287) (← links)
- Pathogenesis of Acute Kidney Injury: Foundation for Clinical Practice (Q30425669) (← links)
- Otoprotective effects of erythropoietin on Cdh23erl/erl mice (Q30439263) (← links)
- Use of high-dose erythropoietin for repair after injury: A comparison of outcomes in heart and kidney (Q30486662) (← links)
- Protective effect of erythropoietin on renal injury induced in rats by four weeks of exhaustive exercise (Q31121975) (← links)
- Hypoxia-inducible factor modulates tubular cell survival in cisplatin nephrotoxicity (Q33217146) (← links)
- The improvement of ischemia/reperfusion injury by erythropoetin is not mediated through bone marrow cell recruitment in rats (Q33450073) (← links)
- Plant-Produced Asialo-Erythropoietin Restores Pancreatic Beta-Cell Function by Suppressing Mammalian Sterile-20-like Kinase (MST1) and Caspase-3 Activation (Q33575974) (← links)
- The effect of erythropoietin on normal and neoplastic cells (Q34291437) (← links)
- Epoetin administrated after cardiac surgery: effects on renal function and inflammation in a randomized controlled study (Q34433029) (← links)
- Effects of intraosseous erythropoietin during hemorrhagic shock in swine. (Q34445203) (← links)
- Chemotherapy-associated renal dysfunction (Q34609452) (← links)
- Two-step purification procedure for recombinant human asialoerythropoietin expressed in transgenic plants. (Q34663742) (← links)
- Cytoprotective effect of recombinant human erythropoietin produced in transgenic tobacco plants (Q35016979) (← links)
- Erythropoietin (EPO) in acute kidney injury (Q35176135) (← links)
- Erythropoietin in the intensive care unit: beyond treatment of anemia (Q35574024) (← links)
- Cytoprotective Effect of Ferritin H in Renal Ischemia Reperfusion Injury (Q35778470) (← links)
- Erythropoietin as an antiapoptotic, tissue-protective cytokine. (Q35831214) (← links)
- Protecting mitochondrial bioenergetic function during resuscitation from cardiac arrest (Q35846720) (← links)
- Effects of long-acting erythropoietin analog darbepoetin-α on adriamycin-induced chronic nephropathy (Q35867619) (← links)
- Erythropoietin produced by genetic-modified NIH/3T3 fibroblasts enhances the survival of degenerating neurons (Q36023825) (← links)
- The expression of EPOR in renal cortex during postnatal development (Q36120040) (← links)
- Pleiotropic renal actions of erythropoietin (Q36144411) (← links)
- Effect of high-dose erythropoietin on graft function after kidney transplantation: a randomized, double-blind clinical trial (Q36199501) (← links)
- Impact of increased erythropoietin receptor expression and elevated serum erythropoietin levels on clinicopathological features and prognosis in renal cell carcinoma (Q36224287) (← links)
- Estrogen Abolishes Protective Effect of Erythropoietin against Cisplatin-Induced Nephrotoxicity in Ovariectomized Rats (Q36415213) (← links)
- The VHL/HIF oxygen-sensing pathway and its relevance to kidney disease (Q36419224) (← links)
- Erythropoietin and the cardiorenal syndrome: cellular mechanisms on the cardiorenal connectors (Q36555238) (← links)
- Novel renoprotective actions of erythropoietin: new uses for an old hormone (Q36556717) (← links)
- Mechanisms of disease: Cell death in acute renal failure and emerging evidence for a protective role of erythropoietin (Q36577097) (← links)
- EPO: renoprotection beyond anemia correction (Q36587670) (← links)
- Mechanisms of disease: erythropoietin--an old hormone with a new mission? (Q36600985) (← links)
- Glutaraldehyde erythropoietin protects kidney in ischaemia/reperfusion injury without increasing red blood cell production (Q36603218) (← links)
- Bench-to-bedside review: Erythropoietin and its derivatives as therapies in critical care (Q36633772) (← links)
- Experimental models of acute renal failure and erythropoietin: what evidence of a direct effect? (Q36819627) (← links)
- Nephroprotective effect of estrogen and progesterone combination on cisplatin-induced nephrotoxicity in ovariectomized female rats (Q36887178) (← links)
- Erythropoietin expands a stromal cell population that can mediate renoprotection (Q36956699) (← links)
- Multiple doses of erythropoietin impair liver regeneration by increasing TNF-alpha, the Bax to Bcl-xL ratio and apoptotic cell death (Q36993016) (← links)
- Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure (Q37038424) (← links)
- Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy (Q37082467) (← links)
- Early detection of acute kidney injury: emerging new biomarkers. (Q37084913) (← links)
- Medical therapy of acute kidney injury (Q37088297) (← links)
- Hypoxia-inducible factor signaling in the development of tissue fibrosis (Q37140405) (← links)
- Effects of Fennel Essential Oil on Cisplatin-induced Nephrotoxicity in Ovariectomized Rats. (Q37198928) (← links)
- Multiorgan-protective actions of blockers of the renin-angiotensin system, statins and erythropoietin: common pleiotropic effects in reno-, cardio- and neuroprotection (Q37247753) (← links)
- Pretreatment with darbepoetin attenuates renal injury in a rat model of cisplatin-induced nephrotoxicity (Q37320966) (← links)
- Therapeutic and predictive targets of AKI. (Q37339377) (← links)